Select Committee on Assisted Dying for the Terminally Ill Bill Minutes of Evidence


Examination of Witnesses (Questions 1600 - 1620)

FRIDAY 17 DECEMBER 2004

MR JACOB KOHNSTAMM and DR ROB JONQUIERE

  Q1600  Chairman: These figures that we have been given, which come to about 1,000, 0.7 per cent of the total—do these derive, as far as you understand from the coroners' certificates and investigations, in unnatural death?

  Dr Jonquiere: No, they derive from the research by van der Wal and van der Maas, which is a repeated survey performed by doctors interviewing colleagues with, before that, a statement by the prosecuting office that all information given in the case of this research would not be a reason for prosecution. There was such an enormous response to this research—which I believe is statistically famous internationally—that van der Wal has said that the numbers he received from a certain number of doctors could be extrapolated to the whole population. That is the reason why The Netherlands can produce figures about how many times euthanasia is performed and what percentage of that euthanasia is or is not reported, and how many times termination of life without request is performed. That is on the basis of research. Only a part of these cases are reported, I admit, but still the cases are reported.

  Mr Kohnstamm: So it is not the coroner's business, but it is research business.

  Q1601  Chairman: I do not completely understand, particularly in view of what the government people told us yesterday, what has happened to the information the coroner gets about unnatural deaths and what use, if any, is made of that.

  Dr Jonquiere: It depends on what he finds out. If the coroner finds out that the unnatural death is because of a criminal act, he will certainly report that to the prosecutor.

  Q1602  Chairman: Yes, but what happens to his record? Does the coroner's decision in relation to any unnatural death go into the central government data?

  Dr Jonquiere: I think it goes into the prosecuting office.

  Q1603  Chairman: You have responsibility for the data now?

  Mr Kohnstamm: Yes!

  Dr Jonquiere: He is defending it.

  Mr Kohnstamm: That is correct. It is first the prosecutor's office, and then there is the Holland-wide CBS—the centre for statistics. The Remmelink 900 or 1,000 cannot be seen in the prosecutor's office or in the CBS office, because it is research—where doctors were interviewed by doctors, talking in depth about how life ended.

  Q1604  Chairman: I understand that perfectly. The professor's research has figures, but I am still puzzled about the other way in which figures are collected that go into the central archive. They would not be of no use. They are done for a purpose.

  Mr Kohnstamm: Once there is a reported unnatural death, the public prosecutor will then proceed and do whatever is necessary.

  Q1605  Chairman: If he thinks it right to do so, but when—

  Mr Kohnstamm: There are some cases where the chief of the public prosecutors reported that there was an unnatural death reported and they decided, for several reasons, in I think three or four cases in the last couple of years, that they had cases which they would not prosecute. Those are the only figures that come to my mind.

  Lord Joffe: My Lord Chairman, I think that I can clear that up with a question.

  Chairman: I am very happy to hear that.

  Q1606  Lord Joffe: Would the case be that all these 1,000 cases are reported by the doctors concerned as natural death, so that there is no evidence on the certificate that these were unnatural?

  Dr Jonquiere: I do not think all the cases are not reported. I am afraid that many of those are not reported because doctors do not want to be in danger of being prosecuted—which is understandable. Because of all the discussions, however, we have discovered that, more and more, doctors are reporting those cases. Some of them are very brave in reporting them, and even go to court to defend their case. Then they find out that the defence of necessity is applicable in such cases—and in the majority of cases. Unfortunately, we do not yet have 100 per cent reporting on euthanasia. You will not have the 100 per cent on the involuntary euthanasia being reported.

  Lord Joffe: Are you saying that, of the 1,000 cases, most of the doctors would write, "involuntary euthanasia"?

  Q1607  Lord Patel: No. As I understand it, these 1,000 cases are not real cases; they are anecdotal, identified through an interview process, on the basis of a research project. They were never on any death certificate?

  Mr Kohnstamm: No, and this afternoon you may—if I may advise you—ask van der Wal to go over the 900 cases. These 900 cases are not 900 cases as such. They are, for example, in neonatology, severely handicapped newborn babies—problems that are mainly in the medical sphere.

  Chairman: You may rest assured that we will ask the professor about it. What I was concerned about was the other source of information. Yesterday at the government office, I understood from what the lady in the health department told us—and I may have misunderstood—that there were two sources of information. There was the research information that the professor has, which we will hear about later, and also returns to the government through the coroner in respect of all deaths.

  Q1608  Baroness Finlay of Llandaff: Could I ask two short, completely unrelated questions? First, do you have a protocol for the doctors of what to do, what dose to use, and which drug you recommend?

  Mr Kohnstamm: Yes.

  Dr Jonquiere: As an organisation, we do not have it. However, the pharmacists' organisation and, from the beginning of the 1970s, Dr Admiraal, an anaesthesiologist, have advised in this regard. This society has a protocol, of what we call the gold standard of what to use when euthanasia is performed.

  Q1609  Baroness Finlay of Llandaff: What do they recommend?

  Dr Jonquiere: In euthanasia—the injecting?

  Q1610  Baroness Finlay of Llandaff: Yes.

  Dr Jonquiere: First, to cause a deep comatose situation by barbiturate or something like that.

  Q1611  Baroness Finlay of Llandaff: I wondered what the drug was and the dose that they recommend.

  Mr Kohnstamm: Shall we try to get this information to you?

  Dr Jonquiere: It is Nesdonal or something that is used in anaesthesiology. After this deep comatose situation is caused, then we give secondly a curare-like substance to paralyse the breathing muscles. Then the patient dies within a short period. That is considered to be the gold standard.

  Q1612  Baroness Finlay of Llandaff: So the patient dies of asphyxia?

  Dr Jonquiere: Yes.

  Q1613  Baroness Finlay of Llandaff: Having had the coma induced.

  Dr Jonquiere: Yes.

  Baroness Finlay of Llandaff: Has there been any research doing EEG monitoring to be sure that the patient does not regain consciousness before they die? With a short-acting intravenous barbiturate, you could have the patient's induction time very short but, because they are completely paralysed, even if they regained consciousness you would not know—because there would be absolutely no movement. They would not be tearing, as you would have with a caesarean section, because you are not using a surgical knife and causing new pain.

  Lord Patel: But he is not answering whether they are long-acting or short-acting barbiturates.

  Baroness Finlay of Llandaff: No, but we all know that, if you have induced liver enzymes, even long-acting barbiturates have a remarkably short time of action.

  Chairman: You say "we all know", but—

  Baroness Finlay of Llandaff: I am sorry!

  Lord Patel: She was looking at me at the time.

  Q1614  Chairman: I can understand that.

  Dr Jonquiere: I do not know the research on that. As far as I know, the organisation has asked doctors to report on their experience with this medication. On the basis of that report, it is seen as the gold standard—which is so golden that, if the review committee gets a report from a doctor who performs euthanasia and who does not use these barbiturates and curare-like substance, it will certainly ask, "Why did you use potassium chloride?", or whatever.

  Baroness Finlay of Llandaff: Could I ask a completely separate and unrelated question? Why did you call it the "right to die"? We are all going to die. What I do not understand is why you did not call it the "right to euthanasia" or the "right to stop living".

  Chairman: It is not even a right to do that, is it?

  Q1615  Baroness Finlay of Llandaff: No, but a right to euthanasia is what you are arguing for. We all have the right, in fact. Nobody has the right not to die.

  Mr Kohnstamm: As far as the society is concerned, it is called NVVE—the Dutch society for voluntary euthanasia. So there you have your answer. We are not talking about right to die. In the international sphere, yes; but in the Dutch sphere, we stick to the words "euthanasia and assisted suicide", because euthanasia and assisted suicide would always be voluntary.

  Q1616  Baroness Finlay of Llandaff: This is clarity of Dutch thinking, which other people have not adopted.

  Dr Jonquiere: The French talk—if I translate it into English—of the "right to die in dignity". Internationally, maybe the "in dignity" is left out of "right to die"; but that is the meaning of the right-to-die societies.

  Q1617  Baroness Finlay of Llandaff: I wondered what you were campaigning for next, having achieved what you have achieved.

  Dr Jonquiere: Do you have another afternoon?

  Q1618  Earl of Arran: In all the research that you have done into public opinion in this country, to what extent have you done research amongst the young about euthanasia? One day, "our problem" will also be their problem. Have you done much, and what is their opinion?

  Mr Kohnstamm: The research that we as a society have been doing is mainly research amongst our members, and I must admit that the general age of our members is pretty high.

  Q1619  Earl of Arran: I understand that, but do you know what the answer is amongst the research done in the country?

  Mr Kohnstamm: That is the government or other organisations which have dealt with these sorts of interviews. Generally speaking, the support amongst younger and older people is more or less the same. You see it growing the older the age, where people are more affected by this discussion.

  Q1620  Chairman: The time seems to have passed very quickly today, and I fear that we are going to have to stop.

  Dr Jonquiere: We have done a survey or poll in The Netherlands, asking this question and we have it translated into English. We could photocopy these results and leave it for you to read. There is also an indication as to the difference between the age groups.

  Mr Kohnstamm: I am told that you have an interview quite soon after this one. We have therefore ordered a Dutch lunch, and we will leave you with your discussion—perhaps preparing for whatever comes next.

  Chairman: That is very kind. We are very happy to have you stay with us, but you may have something else to do. Thank you very much.






 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2005